HII's $86B Backlog Makes It a Long-Term Defense Play
💡 Key Takeaway
Huntington Ingalls' record $86.2B backlog and 90% contracted revenue through 2030 provide exceptional visibility, making it a solid long-term investment despite execution risks.
What Happened: Backlog Soars on Major Navy Awards
Huntington Ingalls Industries (HII) reported third-quarter 2026 results on October 29, 2026, and raised its full-year shipbuilding revenue forecast to $10.5–$10.7 billion. The defense shipbuilder also revealed a record backlog of $86.2 billion, driven by over $32 billion in new contract awards during the quarter.
These awards include Block VI Virginia-class submarines, two Columbia-class submarine contracts, and long lead time materials for the CVN-82 aircraft carrier. Management called it an 'unprecedented quarter' for contract awards.
The company's Mission Technologies division, which focuses on autonomous systems and unmanned surface vehicles, expanded its Massachusetts production facility by 25% to meet growing demand from the Navy and allied partners.
On the labor front, HII hired over 6,000 shipbuilders year-to-date across its Ingalls and Newport News shipyards. In the third quarter, Ingalls achieved a net increase of 576 shipbuilders—its highest net gain in 10 quarters—improving throughput and production capacity.
Looking ahead, management emphasized that approximately 90% of expected shipbuilding revenue through 2030 is already under contract, providing long-term revenue visibility and stability.
What This Means for Me
Why It Matters: Visibility and Growth for Investors
For investors, the surging backlog is a clear indicator of future revenue. With $86.2 billion in contracted orders, HII has years of work lined up, which reduces uncertainty and supports earnings predictability. The raised revenue guidance further signals management's confidence in near-term execution.
The expansion into autonomous systems positions HII in a high-growth area of defense spending. Unmanned platforms are becoming a larger part of the Navy's strategy, and HII's increased production capacity could capture more of that market, potentially boosting margins over time.
Workforce gains are critical for shipbuilders, as skilled labor is a bottleneck. The net increase in shipbuilders at Ingalls suggests improving productivity and the ability to ramp up production, which should translate into faster revenue recognition and better cost absorption.
Finally, the multiyear nature of Navy contracts shields HII from economic cycles. With 90% of 2030 revenue already booked, the company has a durable foundation to compound earnings, making it an attractive defensive holding in a volatile market.
Stock to Watch
| Stocks | Impact | Analysis | |
|---|---|---|---|
| HII | Positive | Record backlog and raised guidance provide strong revenue visibility, while expansion in autonomous systems and workforce gains support long-term growth. |
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight

HII is a solid long-term buy for investors seeking stable defense exposure with growth upside from autonomous systems.
The company's $86.2 billion backlog and 90% contracted revenue through 2030 offer exceptional predictability. Improving labor and facility expansion should drive margin expansion. Risks include execution challenges and potential defense budget shifts, but the long-term outlook remains strong.
What This Means for Me

Read More
Hayward Q3: Aftermarket Strength Drives Growth
Bullish Hayward's recurring aftermarket revenue (85%+ of sales) and strategic pricing power position it for durable growth despite new pool construction declines.
HAYWNov 12, 2026Nebius Stock Plunges 18% Despite 571% Revenue Growth
Neutral Nebius's explosive revenue growth is overshadowed by execution concerns and the shock resignation of Nvidia's CEO, creating a high-risk buying opportunity for long-term investors.
NBISNVDANov 12, 2026Twist Bioscience: Profitability Unlocks AI-Driven DNA Demand
Bullish Twist Bioscience reached positive adjusted EBITDA and expects 21% revenue growth in FY2027, driven by explosive AI drug discovery demand and expanded manufacturing capacity.
TWSTNov 12, 2026

